{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T06:46:10Z","timestamp":1749105970471},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.2169\/internalmedicine.0560-17","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T22:23:40Z","timestamp":1522362220000},"page":"2573-2579","source":"Crossref","is-referenced-by-count":3,"title":["Successful Treatment of Aggressive Mature B-cell Lymphoma Mimicking Immune Thrombocytopenic Purpura"],"prefix":"10.2169","volume":"57","author":[{"given":"Koya","family":"Ono","sequence":"first","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Onishi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Hatta","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"},{"name":"Department of Hematology, National Cancer Center Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Okitsu","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ichinohasama","sequence":"additional","affiliation":[{"name":"Division of Hematopathology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Cines DB, McMillan R. Pathogenesis of chronic immune thrombocytopenic purpura. Curr Opin Hematol 14: 511-514, 2007.","DOI":"10.1097\/MOH.0b013e3282ba5552"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood 113: 6511-6521, 2009.","DOI":"10.1182\/blood-2009-01-129155"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Rogers KA, Woyach JA. Secondary autoimmune cytopenias in chronic lymphocytic leukemia. Semin Oncol 43: 300-310, 2016.","DOI":"10.1053\/j.seminoncol.2016.02.011"},{"key":"4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3324\/haematol.11934","volume":"93","author":"AW Hauswirth","year":"2008","unstructured":"4. Hauswirth AW, Skrabs C, Sch\u00fctzinger C, et al. Autoimmune thrombocytopenia in non-Hodgkin&apos;s lymphomas. Haematologica 93: 447-450, 2008.","journal-title":"Haematologica","ISSN":"http:\/\/id.crossref.org\/issn\/0390-6078","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(09)60402-5","volume":"373","author":"JB Bussel","year":"2009","unstructured":"5. Bussel JB, Provan D, Shamsi T, et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet 373: 641-648, 2009.","journal-title":"The Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Kuter DJ, Bussel JB, Lyons RM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomized controlled trial. Lancet 371: 395-403, 2008.","DOI":"10.1016\/S0140-6736(08)60203-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Landgren O, Engels EA, Pfeiffer RM, et al. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst 98: 1321-1330, 2006.","DOI":"10.1093\/jnci\/djj361"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Anderson LA, Gadalla S, Morton LM, et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer 125: 398-405, 2009.","DOI":"10.1002\/ijc.24287"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Visco C, Rodeghiero F. Immune thrombocytopenia in lymphoproliferative disorders. Hematol Oncol Clin North Am 23: 1261-1274, 2009.","DOI":"10.1016\/j.hoc.2009.08.006"},{"key":"10","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood.V63.4.944.944","volume":"63","author":"AW Berkman","year":"1984","unstructured":"10. Berkman AW, Kickler T, Braine H. Platelet-associated IgG in patients with lymphoma. Blood 63: 944-948, 1984.","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Braik T, Evans AT, Telfer M, McDunn S. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review. Am J Med Sci 340: 301-308, 2010.","DOI":"10.1097\/MAJ.0b013e3181d9bb3b"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 349: 1543-1554, 2003.","DOI":"10.1056\/NEJMra023009"},{"key":"13","unstructured":"13. Nobuoka A, Sakamaki S, Kogawa K, et al. A case of malignant lymphoma producing autoantibody against platelet glycoprotein Ib. Int J Hematol 70: 200-206, 1999."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Iioka F, Honjo G, Misaki T, et al. A unique subtype of diffuse large B-cell lymphoma primarily involving the bone marrow, spleen, and liver, defined by fluorodeoxyglucose-positron emission tomography combined with computed tomography. Leuk Lymphoma 57: 2593-2602, 2016.","DOI":"10.3109\/10428194.2016.1154959"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Glaspy JA, Jacobs AD, Golde DW. Evolving therapy of hairy cell leukemia. Cancer 59: 652-657, 1987.","DOI":"10.1002\/1097-0142(19870201)59:3+<652::AID-CNCR2820591314>3.0.CO;2-A"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Moriwaki Y, Naka M, Yamamoto T, et al. Malignant lymphoma in the mesentery with immune thrombocytopenia. Intern Med 31: 1185-1189, 1992.","DOI":"10.2169\/internalmedicine.31.1185"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Baudard M, Pagnoux C, Audouin J, et al. Idiopathic thrombocytopenic purpura as the presenting feature of a primary bilateral adrenal non Hodgkin&apos;s lymphoma. Leuk Lymphoma 26: 609-613, 1997.","DOI":"10.3109\/10428199709050897"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yamamoto E, Ozaki N, Nakagawa M, Kimoto M. Primary bilateral adrenal lymphoma associated with idiopathic thrombocytopenic purpura. Leuk Lymphoma 35: 403-408, 1999.","DOI":"10.3109\/10428199909145746"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Uchiyama M, Sato K, Ikeda T. Diffuse large B-cell lymphoma complicated with autoimmune thrombocytopenia. Intern Med 50: 1215-1218, 2011.","DOI":"10.2169\/internalmedicine.50.4848"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tan J, Wei J, Ni X, Zhou J. Immune thrombocytopenic purpura occurred prior to multiple extranodal diffuse large B cell lymphoma. Platelets 22: 81-83, 2011.","DOI":"10.3109\/09537104.2010.517582"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Park SY, Kim S, Kim ES, et al. A case of non-Hodgkin&apos;s lymphoma in patient with Coombs&apos; negative hemolytic anemia and idiopathic thrombocytopenic purpura. Cancer Res Treat 44: 69-72, 2012.","DOI":"10.4143\/crt.2012.44.1.69"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Berrang T, Holloway C, Hart J, Yee A, Berry B, Kotb R. Successful treatment of non-Hodgkin lymphoma associated immune thrombocytopenia with involved field radiotherapy. Hematol Oncol 31: 218-220, 2013.","DOI":"10.1002\/hon.2048"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Takahashi T, Maruyama Y, Saitoh M, et al. Synchronous occurrence of diffuse large B-cell lymphoma of the duodenum and gastrointestinal stromal tumor of the ileum in a patient with immune thrombocytopenic purpura. Intern Med 55: 2951-2956, 2016.","DOI":"10.2169\/internalmedicine.55.6712"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Czuczman MS, Olejniczak S, Gowda A, et al. Acquirement of rituximab resistance in lymphoma cell lines is associated with both global CD20 gene and protein down-regulation regulated at the pretranscriptional and posttranscriptional levels. Clin Cancer Res 14: 1561-1570, 2008.","DOI":"10.1158\/1078-0432.CCR-07-1254"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Johnson NA, Boyle M, Bashashati A, et al. Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival. Blood 113: 3773-3780, 2009.","DOI":"10.1182\/blood-2008-09-177469"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Miyagi AM, Taniguchi H, Nomoto J, et al. Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin&apos;s lymphoma after rituximab therapy. Cancer Sci 100: 54-61, 2009.","DOI":"10.1111\/j.1349-7006.2008.01005.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Miyoshi H, Arakawa F, Sato K, et al. Comparison of CD20 expression in B-cell lymphoma between newly diagnosed, untreated cases and those after rituximab treatment. Cancer Sci 103: 1567-1573, 2012.","DOI":"10.1111\/j.1349-7006.2012.02307.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/17\/57_0560-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T18:14:02Z","timestamp":1570990442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/17\/57_0560-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":27,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0560-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,1]]}}}